Good point. I have always felt that as painful as it may be, IPIX likely has many options to sell off the drug compounds to generate enough money to keep going on the remaining drugs if they were ever were to get to a point of the binary choice to sell or go bankrupt. Some may argue why any company would even offer IPIX money for one of their drugs if they had the potential to go bankrupt because then said company could theoretically get the compounds even cheaper by buying IPIX once they were collapsed. But I think the drugs are too valuable for a smart bio firm to wait that long. They would jump on a fire sale of Briliciden for maybe a hundred million or more before they'd let another company pounce on it. P is easily worth tens of millions in an absolute lowest valuation, they could sell that too.
IF, and I repeat IF, IPIX were to ever have to make hard choices like that I believe they will survive and still make some money for us investors that have low price points. It definitely will not be generational wealth in those scenarios, but it would still be a lucrative investment.

I truly believe we are WAY past the likelihood of the scenario of bankruptcy.
The trials have ALL been successful to date, the drugs are SAFE, there are minimal to NO SIDE-EFFECTS, the potential markets for their treatments are HUGE, the delivery of all of their drugs are going to ultimately be ORAL and the MOST CONVENIENT for patients, the manufacture and distribution will be relatively INEXPENSIVE (adding even more value), and for the most part the drugs are meeting UNMET NEEDS.

Our Investment is SOLID and in good hands right now. I think I am going to buy some more shares today!!!!